GEO-CM04S1 Designed to Deliver Broader, More Durable Protection for the 40 Million Americans Left Vulnerable by Limited ...
The prize honored discoveries that defined peripheral immune tolerance through regulatory T cells (Tregs) and the FOXP3 gene, ...
Breakthrough method turns ‘cold’ tumors into immune targets, raising hope for lasting cancer control - Anadolu Ajansı ...
Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...
About 90% of people in the Lower Mainland of British Columbia have detectable antibodies against measles, indicating robust ...
AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results